 |
bupivacaine hydrochloride |
|---|---|
| Trade Name | |
| Orphan Indication | Treatment of pain associated with postherpetic neuralgia |
| USA Market Approval | USA |
| USA Designation Date | 2016-05-31 00:00:00 |
| Sponsor | Grace Therapeutics, LLC;675 U.S. 1;North Brunswick Township, New Jersey, 08902 |
